Authors:
Patat, A
Rosenzweig, P
Enslen, M
Trocherie, S
Miget, N
Bozon, MC
Allain, H
Gandon, JM
Citation: A. Patat et al., Effects of a new slow release formulation of caffeine on EEG, psychomotor and cognitive functions in sleep-deprived subjects, HUM PSYCHOP, 15(3), 2000, pp. 153-170
Authors:
Wrynn, AS
Mac Sweeney, CP
Franconi, F
Lemaire, L
Pouliquen, D
Herlidou, S
Leonard, BE
Gandon, JM
de Certaines, JD
Citation: As. Wrynn et al., An in-vivo magnetic resonance imaging study of the olfactory bulbectomizedrat model of depression, BRAIN RES, 879(1-2), 2000, pp. 193-199
Authors:
Allain, H
Schuck, S
Lebreton, S
Strenge-Hesse, A
Braun, W
Gandon, JM
Brissot, P
Citation: H. Allain et al., Aminotransferase levels and silymarin in de novo tacrine-treated patients with Alzheimer's disease, DEMENT G C, 10(3), 1999, pp. 181-185
Authors:
Patat, A
Rosenzweig, P
Miget, N
Allain, H
Gandon, JM
Citation: A. Patat et al., Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions inhealthy sleep-deprived subjects, FUN CL PHAR, 13(5), 1999, pp. 582-594
Authors:
Patat, A
Chaufour, S
Gandon, JM
Allain, H
Rosenzweig, P
Citation: A. Patat et al., Safety and pharmacodynamics of single ascending doses of SL34.0026, a new reversible and selective MAO-B inhibitor in healthy subjects, BR J CL PH, 47(5), 1999, pp. 584-585